{
  "url": "https://openlegislation.uk/misuse-of-drugs-designation-amendment-england-wales-and-scotland-order-2017/article-2",
  "json_url": "https://openlegislation.uk/misuse-of-drugs-designation-amendment-england-wales-and-scotland-order-2017/article-2.json",
  "legislation": "uksi/2017/632",
  "legislation_title": "The Misuse of Drugs (Designation) (Amendment) (England, Wales and Scotland) Order 2017",
  "legislation_url": "https://openlegislation.uk/misuse-of-drugs-designation-amendment-england-wales-and-scotland-order-2017",
  "path": "article/2",
  "kind": "article",
  "number": "2",
  "heading": "Amendment to the Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015",
  "text": "(1) The Misuse of Drugs (Designation) (England, Wales and Scotland) Order 2015 is amended as follows.\n(2) In paragraph 1(a) of Part 1 of the Schedule—\n(a) before “Bufotenine” insert—\n“Adinazolam (1-(8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine)\nN-Benzyl-ethylphenidate\nBromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)”;\n(b) after “Cathinone” insert—\n“4’-Chlorodiazepam (7-Chloro-5-(4-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)\nClonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)”;\n(c) after “Concentrate of poppy-straw” insert—\n“Deschloroetizolam (2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)\n3,4-Dichloroethylphenidate\n3,4-Dichloromethylphenidate (3,4-DCMP)\nDiclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)\nEthylnaphthidate\nEthylphenidate”;\n(d) after “Eticyclidine” insert—\n“Etizolam”;\n(e) after “Etryptamine” insert—\n“Flubromazepam (7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)\nFlubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)\n4-Fluoroethylphenidate\n4-Fluoromethylphenidate\nFonazepam (5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”;\n(f) after “Gamma-butyrolactone” insert—\n“3-Hydroxyphenazepam (7-Bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one)\nIsopropylphenidate (IPP or IPPD)”;\n(g) after “Lysergide and other N-alkyl derivatives of lysergamide” insert—\n“Meclonazepam (5-(2-Chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one)”;\n(h) after “Methcathinone” insert—\n“4-Methylmethylphenidate\nMethylmorphenate\nMethylnaphthidate (HDMP-28)\nMetizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)\nNifoxipam (5-(2-Fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2- one)\nNitrazolam (1-Methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)\nPropylphenidate”;\n(i) after “Psilocin” insert—\n“Pyrazolam (8-Bromo-1-methyl-6-(2-pyridinyl)-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)”;\n(j) after “3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide (AH-7921)” insert—\n“3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47,700)”.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 2015/704 as amended by S.I. 2016/1124."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2017/632/article/2",
    "retrieved_at": "2026-10-28T23:10:36.063253+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}